EsophaCap for the Detection of Early Esophageal Carcinoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorJohns Hopkins University
About this trial
This study is to identify potential biomarkers for the early detection of Barrett's Esophagus, esophageal carcinoma (both adenocarcinoma and squamous cell carcinoma), and gastric cancer via sponge cytology.
Eligibility criteria
Qualifiers
Undergoing esophagogastroduodenoscopy at Johns Hopkins Hospital from 1/2016 to 12/2025
Age greater than 18 years
Patients must be able to swallow a capsule
Disqualifiers
Patients in either arm with extra-esophageal malignancies including head and neck and gastric cancer
Patients who have undergone esophagectomy
Patients who have undergone radiation to the chest
Patients who are younger than 18
Trial design
Treatments tested in this trial
- Not listed
Trial groups
2,500 Participants
are grouped into 4 trial groupsSponsors and collaborators
Johns Hopkins University
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
Source ClinicalTrials.gov